-
Palonosetron Hydrochloride: Receptor–Renal Axis
2026-09-07
Palonosetron hydrochloride is a highly selective 5-HT3 receptor antagonist with unusually durable receptor pharmacology. This article connects nanomolar 5-HT3 signaling assays with micromolar OCT2 and MATE1 transporter studies to improve model selection, concentration design, and translational interpretation in cancer research.
-
SU 5402 Workflows for RTK Signaling Research
2026-09-05
SU 5402 provides a practical way to interrogate VEGFR2, FGFR1, PDGFRβ, and downstream ERK1/2–STAT3 signaling across cancer biology and emerging human neuronal models. This guide connects dose-finding, phospho-protein analysis, apoptosis assay design, and troubleshooting while clearly separating established evidence from exploratory HSV-1 applications.
-
Spermine Workflows for Ion Channel Research
2026-09-05
Spermine supports controlled studies of inward rectifier potassium channel modulation, polyamine-dependent cell physiology, and cellular metabolism. This workflow-driven guide also shows how to use the CLCC1 herpesvirus study as a careful membrane-morphogenesis comparison without overstating what the evidence proves.
-
Phenothiazines Boost Macrophage Antibacterial Defense
2026-09-04
Qiu and colleagues show that phenothiazines can strengthen macrophage control of intracellular bacteria by increasing reactive oxygen species, lysosomal activity, and autophagy. The study positions perphenazine as a lead compound for host-directed antibacterial research, while also identifying important mechanistic and translational limitations.
-
7-dehydro Cholesterol: From Sterol Flux to Immunity
2026-09-04
Explore how 7-dehydro Cholesterol functions as a metabolic substrate, photobiology probe, and interpretive variable in DHCR7 research. This evidence-based guide connects sterol measurements with UVB, oxidation, and antiviral phenotyping while emphasizing practical assay decisions.
-
PP 1 Maps Src Signaling in HER2-Resistant Cancer
2026-09-03
PP 1, a Src family tyrosine kinase inhibitor, can serve as a mechanistic probe for separating Src-dependent signaling from HER2 and EDI3 biology. This article develops a pathway-mapping strategy for resistant breast cancer models while defining assay controls, limitations, and translational boundaries.
-
Bobcat339: Mapping TET-Driven DNA Methylation
2026-09-03
Bobcat339 is a cytosine structure-based TET enzyme inhibitor for dissecting DNA methylation regulation and gene transcription modulation. This article presents a practical, multi-omic assay strategy that separates direct TET inhibition from downstream enhancer and cell-state effects.
-
PCMT1 and Ovarian Cancer Metastasis: CRISPR Evidence
2026-09-02
Zhang et al. used a genome-wide CRISPR/Cas9 screen to identify PCMT1 as a regulator of anoikis resistance and ovarian cancer metastasis. The study connects extracellular PCMT1 to LAMB3–integrin–FAK-Src signaling, providing a mechanistic framework for how tumor cells interact with the extracellular matrix during dissemination.
-
Human iPSC Sensory Neurons Model HSV-1 Latency
2026-09-02
Oh et al. developed a scalable human iPSC-derived sensory neuron system that supports experimentally defined HSV-1 latency and reactivation. The model combines neuronal functional validation with virological, transcriptional, and chromatin-based latency criteria, providing a human-relevant platform for studying neuron-intrinsic infection mechanisms.
-
Vaccinia F1L and NLRP1 Inflammasome Evasion
2026-09-01
Szymanska et al. show that the vaccinia virus protein F1L selectively suppresses dsRNA- and ribotoxic stress-dependent NLRP1 inflammasome activation while leaving DPP9-inhibition-mediated activation intact. Their experiments place F1L partly upstream of the ZAKα stress-signaling pathway and clarify how viral control of translation can disable epithelial innate immunity.
-
One-step TUNEL Cy3 Apoptosis Detection Kit
2026-08-31
A scenario-driven guide to selecting, running, and interpreting the One-step TUNEL Cy3 Apoptosis Detection Kit, SKU K1134, for DNA fragmentation analysis in cells and tissue. It connects assay chemistry, controls, sample compatibility, and vendor-selection considerations to practical apoptosis research decisions.
-
n-Dodecyl-β-D-maltoside for Cryo-EM
2026-08-31
n-Dodecyl-β-D-maltoside, or DDM, offers a practical route to extract and stabilize full-length membrane complexes without the harshness of ionic detergents. This article translates its chemistry into cryo-EM preparation, ligand-state screening, protein–lipid interaction studies, and troubleshooting for conformationally dynamic receptors.
-
GRK Regulation of BQCA-M1 Signaling Bias
2026-08-30
This study uses dynamic BRET measurements to define how GRK2/3 and GRK5/6 differentially regulate M1 muscarinic receptor coupling to G proteins and β-arrestin 2. Its analysis positions BQCA as a useful probe of M1 signaling bias while showing that GRK subtype balance, rather than receptor activation alone, may shape downstream pathway preference.
-
IGFBP2–THBS1 Mechanism in GH Therapy for ISS
2026-08-29
This study identifies an IGFBP2–THBS1 regulatory axis that helps explain how growth hormone promotes chondrocyte proliferation, hypertrophic differentiation, and IGF-1 signaling in idiopathic short stature. Its combination of patient plasma data, bioinformatic prediction, and gain- and loss-of-function experiments provides a mechanistic framework for evaluating growth hormone responses beyond the conventional GH–IGF-1 model.
-
Phenothiazines, ROS, and Macrophage Antibacterial Defense
2026-08-29
Qiu et al. show that phenothiazines strengthen macrophage control of intracellular bacteria by coordinating reactive oxygen species accumulation, lysosomal activity, and autophagy. The study supports a host-directed strategy in which Perphenazine and related compounds enhance innate antibacterial function rather than relying solely on direct bacterial killing.